Leah L Thompson1, Brandon Temel2, Charn-Xin Fuh2, Christine Server3, Paul Kay2, Sophia Landay2, Daniel E Lage2, Lara Traeger4, Erin Scott5, Vicki A Jackson5, Joseph A Greer4, Areej El-Jawahri2, Jennifer S Temel2, Ryan D Nipp2. 1. Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA, USA. Electronic address: leah_thompson@hms.harvard.edu. 2. Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA, USA. 3. University of Maryland School of Medicine, Baltimore, MD, USA. 4. Department of Psychiatry, Massachusetts General Hospital & Harvard Medical School, Boston, MA, USA. 5. Department of Medicine, Division of Palliative Care and Geriatrics, Massachusetts General Hospital & Harvard Medical School, Boston, MA, USA.
Abstract
BACKGROUND: Patient-reported medical status and treatment goal are measures of prognostic understanding with demonstrated relationships to important clinical and patient-reported outcomes in the general cancer population. Among older adults, relationships between these measures and other patient-reported (quality of life [QOL], symptoms, functional impairment) and clinical (hospitalization risk, survival) outcomes remains unclear. METHODS: We enrolled patients ≥70 with advanced gastrointestinal cancers, collecting patient-reported medical status (terminally ill vs not), treatment goal (curative vs non-curative), QOL (EORTC-Elderly Cancer Patients), symptoms (Edmonton Symptom Assessment System [ESAS]), and functional impairment (activities of daily living [ADLs]). We also obtained information about hospitalizations and survival. To explore relationships between patient-reported medical status, treatment goal, QOL, symptoms, functional impairment, hospitalizations, and survival, we used regression models adjusted for age, sex, and education. RESULTS: Of 103 patients, 49.5% reported terminally ill status and 64.0% a non-curative treatment goal. Terminally ill status was associated with worse QOL (EORTC illness burden: 53.59 vs 35.26, p = 0.001), higher symptom burden (ESAS: 28.15 vs 16.79, p = 0.002), more functional impairment (ADLs: 3.63 vs 5.24, p = 0.006), greater hospitalization risk (HR = 2.41, p = 0.020), and worse survival (HR = 1.93, p = 0.010). We did not find associations between patient-reported treatment goal and these outcomes. CONCLUSIONS: In older adults with advanced cancer, report of terminally ill status was associated with other important patient-reported and clinical outcomes, suggesting disease severity may inform illness perceptions. We did not find similar associations for patient-reported treatment goal, indicating that questions related to medical status and treatment goal measure different constructs and more nuanced measures are needed. Published by Elsevier Ltd.
BACKGROUND:Patient-reported medical status and treatment goal are measures of prognostic understanding with demonstrated relationships to important clinical and patient-reported outcomes in the general cancer population. Among older adults, relationships between these measures and other patient-reported (quality of life [QOL], symptoms, functional impairment) and clinical (hospitalization risk, survival) outcomes remains unclear. METHODS: We enrolled patients ≥70 with advanced gastrointestinal cancers, collecting patient-reported medical status (terminally ill vs not), treatment goal (curative vs non-curative), QOL (EORTC-Elderly CancerPatients), symptoms (Edmonton Symptom Assessment System [ESAS]), and functional impairment (activities of daily living [ADLs]). We also obtained information about hospitalizations and survival. To explore relationships between patient-reported medical status, treatment goal, QOL, symptoms, functional impairment, hospitalizations, and survival, we used regression models adjusted for age, sex, and education. RESULTS: Of 103 patients, 49.5% reported terminally ill status and 64.0% a non-curative treatment goal. Terminally ill status was associated with worse QOL (EORTC illness burden: 53.59 vs 35.26, p = 0.001), higher symptom burden (ESAS: 28.15 vs 16.79, p = 0.002), more functional impairment (ADLs: 3.63 vs 5.24, p = 0.006), greater hospitalization risk (HR = 2.41, p = 0.020), and worse survival (HR = 1.93, p = 0.010). We did not find associations between patient-reported treatment goal and these outcomes. CONCLUSIONS: In older adults with advanced cancer, report of terminally ill status was associated with other important patient-reported and clinical outcomes, suggesting disease severity may inform illness perceptions. We did not find similar associations for patient-reported treatment goal, indicating that questions related to medical status and treatment goal measure different constructs and more nuanced measures are needed. Published by Elsevier Ltd.
Authors: Melisa L Wong; Francesca M Nicosia; Alexander K Smith; Louise C Walter; Vivian Lam; Harvey Jay Cohen; Kah Poh Loh; Supriya G Mohile; Carling J Ursem; Margaret L Schwarze Journal: J Geriatr Oncol Date: 2022-02-02 Impact factor: 3.929
Authors: Lauren E Sigler; Andrew D Althouse; Teresa H Thomas; Robert M Arnold; Douglas White; Thomas J Smith; Edward Chu; Margaret Rosenzweig; Kenneth J Smith; Yael Schenker Journal: JCO Oncol Pract Date: 2021-11-12
Authors: Kah Poh Loh; Christopher L Seplaki; Chandrika Sanapala; Reza Yousefi-Nooraie; Jennifer L Lund; Ronald M Epstein; Paul R Duberstein; Marie Flannery; Eva Culakova; Huiwen Xu; Colin McHugh; Heidi D Klepin; Po-Ju Lin; Erin Watson; Valerie Aarne Grossman; Jane Jijun Liu; Jodi Geer; Mark A O'Rourke; Karen Mustian; Supriya G Mohile Journal: JAMA Netw Open Date: 2022-02-01
Authors: Kah Poh Loh; Huiwen Xu; Ronald M Epstein; Supriya G Mohile; Holly G Prigerson; Sandra Plumb; Susan Ladwig; Sindhuja Kadambi; Melisa L Wong; Colin McHugh; Amy An; Kelly Trevino; Fahad Saeed; Paul R Duberstein Journal: J Pain Symptom Manage Date: 2020-02-13 Impact factor: 5.576